In the current climate , im3NY would be in the spotlight with competitors and other developers
I cant see any problem trying to protect intellectual property
there is no requirement to give away confidential developments
the board has every right to be tactical , in what they reveal and what photographs they publish
competitors can do their own research and development.
As i have said before , i have been holding this stock for a good period of time , it has already surpassed my short term expectations
I am confident in the mid/long term this company, may become a life changing organisation for holders
- Forums
- ASX - By Stock
- $1 by EOY
In the current climate , im3NY would be in the spotlight with...
-
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online